AzTrials
AzTrials

DepressionNCT00381979

Supportive Expressive Therapy for Depressed and Anxious Adolescents

A study testing Supportive Expressive Therapy in people with Depression and Anxiety, run by Centre for Addiction and Mental Health at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to investigate the effectiveness of providing Supportive Expressive Therapy to adolescents who are depressed and/or anxious. Read more about this study

Who is it for?
Ages 15 to 24 years
Conditions the study is for
Depression, Anxiety
What is being tested?
Supportive Expressive Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteCanada
Study dates
Jan 2004to Oct 2007
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 24 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • 15-24 year old, male \& female adolescents, primary diagnosis of depression or anxiety disorder.
  • Clients with co-morbid diagnoses, suicidal ideation or taking medication would not necessarily be excluded if deemed able to partake in the proposed therapy.
  • Medication dose needs to be stable for 4-6 weeks prior to starting therapy.

Who cannot join

  • Clients who are actively psychotic, developmentally delayed, or have a diagnosis of bipolar disorder.
  • Clients who are not fluent in English.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Centre for Addiction and Mental Health

    Toronto, Ontario, M5T1R8

Other trials in Canada

About this study

The purpose of the study is to investigate the effectiveness of providing Supportive Expressive Therapy to adolescents who are depressed and/or anxious.

Read the detailed description

Supportive Expressive Therapy (SET; a 16 session manualized form of psychodynamic therapy) has been well utilized with adult clients. To date, there is no known systematic study into the benefit of this method of therapy with adolescents who are depressed and/or anxious. It is thought that SET would be useful for this population as it is similar in principle to Interpersonal Relationship Therapy (IPT), which has been shown to be effective for use with depressed adults and youth. Both IPT and SET help clients explore the role they play within challenging relationships in their lives. SET, however, allows for the exploration of more relationships within the adolescents' circle. Moreover, SET explores the adolescents' perceptions of themselves, others, and their wish in relationships. Further, the SET method is more easily individualized in that it affords greater flexibility in design and possibility for change over time. Accordingly, the purpose of this study is to explore the feasibility of utilizing this method of therapy with adolescents who are depressed and anxious. We will be exploring the effectiveness of SET through the resolution of depressed and/or anxious adolescents' conflictual relationships thereby reducing their symptomatology.

Conditions
Depression, Anxiety
Being tested
Supportive Expressive Therapy
Keywords
Depression, Anxiety, Adolescents, Treatment, Supportive Expressive Therapy
Medical subject headings
Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Supportive Expressive TherapyOther

    Also called therapy

Study groups in NCT00381979
Study groupRoleWhat they receive
1Experimentalset
Receives: Other: Supportive Expressive Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. BDI

    Measured: pre and post

  2. MASC

    Measured: pre and post

  3. Measures collected at pre, post, and follow-up

    Measured: pre and post

Secondary outcomes (6)
  1. YSR

    Measured: pre and post

  2. CBCL

    Measured: pre and post

  3. FAM

    Measured: pre and post

  4. CRI

    Measured: pre and post

  5. SSRS

    Measured: pre and post

  6. Measures collected at pre, post, and follow-up

    Measured: pre and post

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2006 (estimated)
  2. Study startJan 2004
  3. Primary completionOct 2007
  4. Study completionOct 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00381979
Sponsor's protocol ID
169/2003
Status last verified
Sep 2015
First submitted
26 Sep 2006
Last updated
22 Oct 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Supportive Expressive Therapy in people with Depression and Anxiety, run by Centre for Addiction and Mental Health at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Oct 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

BDI (time frame: pre and post). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in